Katrina Thornber, Author at European Medical Journal - Page 26 of 50

Ethnic Disparities in Colorectal Cancer Diagnosis Uncovered in NHS Study

A major NHS study has found significant ethnic disparities in colorectal cancer diagnosis, with non-white patients more likely to develop early-onset CRC but less likely to be diagnosed through urgent referrals.

Scalp Microbiome and Central Centrifugal Cicatricial Alopecia

A recent study examined the scalp microbiome in Black women diagnosed with central centrifugal cicatricial alopecia, compared with matched healthy individuals.

Innovative Video Game Test Detects Autism in Children in One Minute

A one-minute video game, CAMI, identifies autism with 80% accuracy, distinguishing it from ADHD and neurotypical development.

A New Novel Biomarker for Kidney Stones in Hyperparathyroidism

A high calcium-to-magnesium ratio predicts nephrolithiasis in primary hyperparathyroidism, offering enhanced diagnostic accuracy and specificity.

Breaking Barriers: Why COPD Diagnosis Is Often Delayed

A new qualitative study conducted in France highlights the multiple obstacles patients face before receiving a chronic obstructive pulmonary disease diagnosis.

Cannabis Use Linked to Reduced Brain Activity in Memory Tasks

Cannabis use Linked to reduced brain activity in memory tasks, recent studies using fMRI show.

Propranolol’s Surprising Role in Reducing Parkinson’s Tremor

New research shows propranolol reduces Parkinson’s tremor and motor cortex activity, offering a potential treatment option.

Study Confirms Type 2 Diabetes Raises Heart Risks in Atherosclerosis

A new study has confirmed that type 2 diabetes significantly increases the risk of major cardiovascular events, regardless of atherosclerosis severity.

COVAIL Trial Reveals Insights Into Antibody Levels and Vaccine Efficacy

New data from the COVAIL trial highlight the importance of neutralizing antibody titers in reducing COVID-19 risk after mRNA boosters, with stronger protection observed in individuals with prior SARS-CoV-2 infection.

Novel Urine Test Detects Early-Stage Bladder Cancer with 90% Accuracy

A groundbreaking point-of-care urine test detects early-stage bladder cancer with 90% accuracy, bypassing lab processing.